OIT3 increased the expression of PD-L1 in TAMs by activating the nuclear factor kB (NF-κB) signaling pathway, blocked the immunosuppressive activity of NF-κB reversal TAMs, and inhibited the tumorigenesis of HCC (23). The gene discussed is OIT3; the disease is hepatocellular carcinoma.